SLC7A11 and glioma: Polewski et al. [48] confirmed that the cystine/glutamate antiporter system (SLC7A11) is upregulated in glioma, and the overexpression of SLC7A11 enhances the stemness phenotype of glioma stem cells (see Figure 1).